Company intelligence / Profile preview

P.A.L.M. Microlaser Technologies

Bernried, Bavaria, Germany

Ownership: Private
Development stage: Other

Overview

PALM Microlaser Technologies is a pioneer in the field of laser microdissection and pressure catapulting (LMPC) technology, used for the precise isolation of specific cells or tissue areas from microscopic samples. Founded in Germany, the company developed the PALM MicroBeam system, which allows researchers to collect uncontaminated genetic material or proteins for downstream analysis in genomics and proteomics. Its proprietary technology uses a focused laser to cut and then "catapult" the sample into a collection vessel without physical contact. In 2004, the company was acquired by Carl Zeiss, where its technology continues to be a cornerstone of Zeiss's high-end microscopy and life science research portfolio.

Modalities: Device
Industry: Non-Drug Biotech

Beyond the preview

Go deeper on P.A.L.M. Microlaser Technologies.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on P.A.L.M. Microlaser Technologies.

Explore the full profile